
pmid: 38444573
pmc: PMC10910243
AbstractLysosomal storage disorders (LSDs) in adults have milder phenotype and variable age at presentation. Several studies have described the phenotype, genotype and treatment outcomes for adult‐onset LSDs like Gaucher, Fabry, Pompe disease and others. We describe the first systematic study on the occurrence of LSDs in an adult population from India. It describes, the key clinical signs seen in these patients and those from literature review that can aid in early detection. Of 2102 biochemically diagnosed LSDs cases, 32 adult patients were identified with LSDs. Based on the clinical suspicion, screening test and enzyme study was carried out. Twenty‐two patients were subjected to a genetic study to identify the causative variant in a respective gene. Of the 32 adult patients, we observed a maximum percentage of 37.5% (n = 12) cases with Gaucher disease, followed by 13% (n = 4) with Fabry disease. We found 10% of cases with MPS IVA and MPS I, and 9% cases with Pompe. Single case of adult mucolipidosis III and two cases each of Type 1 Sialidosis, Niemann‐Pick disease B and metachromatic leukodystrophy were identified. We observed two common variants p.Leu483Pro and p.Ala487Thr in the GBA1 gene in 23% of Indian patients with adult Gaucher disease. No common variants were observed in other aforementioned LSDs. Study identified 50% of Fabry patients and 4% of Gaucher patients diagnosed at our centre to be adults. The prevalence of adult Pompe patients was low (3.4%) as compared to 80% reported in the Caucasian population. Adult LSDs such as, MPS III, GM1/GM2 gangliosidosis and Krabbe disease were not identified in our cohort.
Glucocerebrosidase, Physiology, Epidemiology, Epidemiology and Treatment of Chagas Disease, Mucopolysaccharidosis I, Population, Age of onset, Lysosomal storage disease, Gaucher disease, QH426-470, Metachromatic leukodystrophy, Pediatrics, Diseases of the endocrine glands. Clinical endocrinology, Lysosomal Storage Disorders, Biochemistry, Genetics and Molecular Biology, Health Sciences, Genetics, Pathology, Disease, Internal medicine, adult‐onset LSDs, Lysosomal Calcium Signaling in Physiology and Pathology, Fabry disease, Gaucher Disease, Life Sciences, Research Reports, Leukodystrophy, RC648-665, Lysosomal Storage Diseases, p.Leu483pro, Environmental health, FOS: Biological sciences, Enzyme replacement therapy, Medicine, Lysosomal Storage Disorders in Human Health and Disease
Glucocerebrosidase, Physiology, Epidemiology, Epidemiology and Treatment of Chagas Disease, Mucopolysaccharidosis I, Population, Age of onset, Lysosomal storage disease, Gaucher disease, QH426-470, Metachromatic leukodystrophy, Pediatrics, Diseases of the endocrine glands. Clinical endocrinology, Lysosomal Storage Disorders, Biochemistry, Genetics and Molecular Biology, Health Sciences, Genetics, Pathology, Disease, Internal medicine, adult‐onset LSDs, Lysosomal Calcium Signaling in Physiology and Pathology, Fabry disease, Gaucher Disease, Life Sciences, Research Reports, Leukodystrophy, RC648-665, Lysosomal Storage Diseases, p.Leu483pro, Environmental health, FOS: Biological sciences, Enzyme replacement therapy, Medicine, Lysosomal Storage Disorders in Human Health and Disease
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
